BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9467555)

  • 1. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism.
    Kubota S; Gunji K; Ackrell BA; Cochran B; Stolarski C; Wengrowicz S; Kennerdell JS; Hiromatsu Y; Wall J
    J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy.
    Kaspar M; Archibald C; De BA; Li AW; Yamada M; Chang CH; Kahaly G; Wall JR
    Thyroid; 2002 Mar; 12(3):187-91. PubMed ID: 11952037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
    Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
    Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native gel electrophoresis and isoelectric focusing of a 64-kilodalton eye muscle protein shows that it is an important target for serum autoantibodies in patients with thyroid-associated ophthalmopathy and not expressed in other skeletal muscle.
    Wall JR; Hayes M; Scalise D; Stolarski C; Nebes V; Kiljanski J; Salvi M; Sato M
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1226-32. PubMed ID: 7714092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.
    Kemp EH; Ridgway JN; Smith KA; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):291-9. PubMed ID: 10971445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
    Mizokami T; Salvi M; Wall JR
    J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin.
    Gunji K; Kubota S; Stolarski C; Wengrowicz S; Kennerdell JS; Wall JR
    Autoimmunity; 1999; 29(1):1-9. PubMed ID: 10052680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
    Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
    J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies in the serum of patients with autoimmune thyroid disorders react with a recombinant 98 amino acid fragment of a full length 64 kDa eye muscle membrane protein which is also expressed in the thyroid.
    Zhang ZG; Dong Q; Rodien P; Alcalde L; Bernard N; Boucher A; Salvi M; Arthurs B; Vassart GM; Ludgate M
    Autoimmunity; 1992; 13(2):151-7. PubMed ID: 1467436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens.
    Gunji K; Kubota S; Swanson J; Kiljanski J; Bednarczuk T; Wengrowicz S; Salvi M; Wall JR
    Thyroid; 1998 Jun; 8(6):553-6. PubMed ID: 9669297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity.
    Miller A; Arthurs B; Boucher A; Liberman A; Bernard N; Rodien P; Salvi M; Wall JR
    Thyroid; 1992; 2(3):197-202. PubMed ID: 1422231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
    Yamada M; Li AW; West KA; Chang CH; Wall JR
    Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against 1D, a recombinant 64-kDa membrane protein, are associated with ophthalmopathy in patients with thyroid autoimmunity.
    Bernard NF; Nygen TN; Tyutyunikov A; Stolarski C; Scalise D; Genovese C; Hayes MB; Ludgate M; Wall JR
    Clin Immunol Immunopathol; 1994 Mar; 70(3):225-33. PubMed ID: 8313659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy.
    Wall JR; Triller H; Boucher A; Bernard NF; Salvi M; Ludgate M
    J Endocrinol Invest; 1993 Dec; 16(11):863-8. PubMed ID: 7511621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.